ReviewJSES reviews, reports, and techniques2025
Exploring the relationship between industry payments and institutional factors among American shoulder and elbow surgery fellowship programs.
Review in JSES reviews, reports, and techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While previous studies have examined trends in industry funding among orthopedic surgeons across various subspecialties, there is limited research focusing on institutional-level evaluations. The purpose of this study was to investigate the relationship between shoulder and elbow surgery fellowship program characteristics and industry payments. Methods: This cross-sectional analysis examined characteristics of shoulder and elbow surgery fellowship programs, including program reputation, academic productivity metrics, region of practice, and total number of fellows, in relation to industry lifetime earnings as of March 2024. Fellowship faculty were identified from the American Shoulder and Elbow Surgeons (ASES) directory, while program data were collected from individual program websites. All ASES fellowship faculty members were confirmed on individual program websites. Each surgeon was searched on the Open Payments Database for their compensation earnings. Prestige factors, including fellowship-affiliated residency rankings, were gathered from Doximity and Newsweek rankings, respectively. Academic productivity metrics, including the Hirsch index (H-index), M-index, Relative Citation Ratio (RCR), weighted RCR, and attending publication rates, were obtained using iCite, Scopus, and ResearchGate databases. Results: We identified 151 ASES fellowship faculty members, including 145 male faculty members and 5 female faculty members, from 34 shoulder and elbow surgery fellowship programs. The mean number of payments per fellowship was 999.32 ± 687.51, resulting in mean fellowship lifetime earnings of $1,125,924.05 ± $1,788,302.048. The top sources of industry funding included royalties ($ 766,904.11 ± $765,382.42; 77.3%) followed by consulting ($163,148.43 ± $337,926.35; 15.8%). While there was a statistically significant increase in total lifetime earnings in fellowship programs associated with a Newsweek ranking of the fellowship-affiliated hospital (Kruskal-Wallis, H = 10.806, Conclusion: Our findings indicate that institutional prestige influences industry funding among ASES shoulder and elbow surgery fellowship programs irrespective of academic productivity metrics. Further investigation of this correlation is warranted to better inform policies aimed at promoting transparency and ethical considerations within medical education. By identifying these influences, future studies can help to refine guidelines that govern interactions between industry and medical professionals, ultimately supporting integrity and transparency in medical education and practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.